BioSpace News Archive

Business

PM Pediatrics, an After-Hours Urgent Care Center for Children, to Open at The Shops on Broadway

SD Urban Retail, a Manhattan-based owner and developer, announced today that it has executed a lease with PM Pediatrics at its shopping center, The Shops on Broadway

March 18, 2019
·
1 min read
Policy

National medical organizations come together to examine how virtual care can improve access and quality

Task force on virtual care to also assess feasibility of national licensure in Canada

March 18, 2019
·
2 min read
Biotech Bay

VIASPACE Subsidiary, Bad Love Cosmetics Company, LLC, Announces Plans For CBD Lip Product Line

VIASPACE Inc. announced that its wholly-owned subsidiary, Bad Love Cosmetics Company, LLC has completed fabrication of the component containers for its CBD lip product line.

March 18, 2019
·
4 min read
FDA

Via Surgical Receives FDA Clearance for Its FasTouch™ Absorbable Fixation System

Via Surgical Ltd, a leading developer of surgical fixation solutions, announced U.S. Food and Drug Administration 510 clearance of the FasTouch™ Absorbable Fixation System.

March 18, 2019
·
2 min read
Business

Dr Joshua Dunaief MD, Renowned Age-Related Macular Degeneration Clinician and Researcher, Joins Mperia Therapeutics Inc. Clinical Advisory Board

Dr. Joshua Dunaief, PhD, MD, the Adele Niessen Professor of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, USA, joins the Clinical Advisory Board (CAB) of Mperia Therapeutics Inc.

March 18, 2019
·
2 min read
Deals

Imara Closes a $63MM Series B Cross-Over Financing

Proceeds to Advance IMR-687 for the Treatment of Sickle Cell Disease (SCD) and Thalassemia, and Expand Company Pipeline

March 18, 2019
·
4 min read
Job Trends

Moleculin Biotech, Inc. to Present at the Oppenheimer 29th Annual Healthcare Conference and the 31st Annual ROTH Conference

Moleculin Biotech, Inc. announced that Walter Klemp, Chairman and CEO and Jonathan Foster, Chief Financial Officer, will present at the following investor conferences:

March 18, 2019
·
2 min read
Policy

Biohaven Secures Priority Review Voucher (PRV) To Expedite Regulatory Review Of Rimegepant Zydis ODT New Drug Application

Rimegepant Zydis orally disintegrating tablet (ODT) is Biohaven’s lead oral CGRP receptor antagonist drug candidate from its NOJECTION™ migraine platform

March 18, 2019
·
7 min read
FDA

Allergan Announces FDA Approval of AVYCAZ® (ceftazidime and avibactam) for Pediatric Patients

Label Now Includes New Data on Use of AVYCAZ for Treatment of cUTI and cIAI in Pediatric Patients 3 Months of Age and Older

March 18, 2019
·
11 min read
Drug Development

Alkahest Doses First Subject in Phase 2 Clinical Trial of Lead Candidate in Patients with Severe Alzheimer’s Disease

Alkahest, Inc. announced the dosing of the first subject with severe Alzheimer’s disease in a Phase 2 clinical trial of GRF6019 in collaboration with development partner Grifols.

March 18, 2019
·
3 min read